Background: Staphylococcus aureus (S. aureus) remains a major global pathogen causing a wide spectrum of diseases. Human adults harbor circulating antibodies against most staphylococcal antigens, which provide little protection against invasive S. aureus infection. Conventional S. aureus vaccines are poised to predominantly repeat the natural, non-protective antibody responses. Objective: We investigated the immunological feasibility of an epitope-focused vaccine targeting the D3 epitope of coproporphyrinogen III oxidase (CgoX), which is recognized by the protective monoclonal antibody anti-CgoX-D3. Methods: The potential of the D3 epitope to break the dominant but non-protective immunity to CgoX was investigated in laboratory mice. The seroprevalence of antibodies against the D3 epitope was investigated in sera from healthy blood donors and patients with S. aureus bacteremia. Results: All sera from 204 healthy blood donors harbored antibodies against CgoX, whereas only 10.3% contained antibodies against the D3 epitope, indicating its immunological subdominance. In patients with invasive S. aureus infection, D3-specific responses were more frequent but remained at low serum concentrations, confirming the quantitative subdominance of the protective D3 epitope. Prime-boosting experiments in mice with combinations of whole CgoX and a CRM197-CgoX-D3 conjugate (D3-CRM) revealed that mice primed and boosted with whole CgoX developed weak D3-specific responses. Boosting CgoX-primed mice with D3-CRM resulted in the generation of robust titers of high-affinity D3 binding antibodies. Conclusions: The immunization history with CgoX markedly influences subsequent D3-specific antibody responses. Epitope-focused vaccination with D3-CRM can overcome the attenuation associated with prior CgoX immunization and elicit high-affinity D3-specific antibodies.
Caspase-3 (CASP3) and caspase-7 (CASP7) are the two major executioner caspases that are proteolytically activated by upstream initiator caspases. They possess almost indistinguishable activity, which has led to the overall view that these caspases have functionally redundant roles. Here, we generate knock-in mice expressing cleavage-resistant CASP3(D175A) or CASP7(D198A). Our results show that proteolytic activation of CASP3 and CASP7 is decisive for their activity in vivo and controls redundant processes during embryonic development as combined expression of both CASP3(D175A) and CASP7(D198A) causes embryonic lethality. In adult mice, however, activation of CASP3 and CASP7 controls different processes in different tissues, without the involvement of apoptosis. While CASP7 activation is required for male fertility by controlling spermatogenesis, CASP3 activation appears crucial for lymphoid tissue development by regulating interferon signalling. Our findings shed light on emerging roles of caspases in non-apoptotic processes and provide impetus for reconsidering their involvement in physiological and pathological conditions.